2025 Exhibitors
AIMnext
Profile
AIMNEXT spun off from AIMMED in 2025 to specialize in the R&D and commercialization of Digital Therapeutics (DTx). We aim to improve healthcare outcomes by providing evidence-based, safe, effective, and equitable software interventions for patients.
Contact
Find us at the event
- Stand number
- 3F2-4